UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000046867
Receipt number R000053390
Scientific Title Effect of visually assisted device of respiratory function monitor on neonatal resuscitation ; Cross-over randomized controlled trial using newborn mannequin
Date of disclosure of the study information 2022/02/08
Last modified on 2023/03/06 11:16:57

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Effect of visually assisted device of respiratory monitor on neonatal resuscitation ; Simulation study using newborn mannequin

Acronym

PPV assist study

Scientific Title

Effect of visually assisted device of respiratory function monitor on neonatal resuscitation ; Cross-over randomized controlled trial using newborn mannequin

Scientific Title:Acronym

PPV assist study

Region

Japan


Condition

Condition

newborn who needs resuscitation

Classification by specialty

Pediatrics Intensive care medicine Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Approximately 15% of newborns cannot establish spontaneous breathing after birth and need some kind of resuscitation. The current standard of care for assessment of effective positive pressure ventilation in neonatal resuscitation is based on physical findings such as thoracic elevation and vital signs detected by pulse oximeter or heart rate monitoring. In addition, there have been recent reports on the usefulness of respiratory function monitors that can measure ventilation volume and pressure.
With the increase in the number of these monitors, there is a concern that resuscitators may focus only on the monitors instead of the neonates. In this study, we will investigate whether the resuscitator's attention can be focused more on the neonate by attaching a visual feedback device that displays alarms by lighting or flashing lights(PPV assist) to a ventilation device and visually displaying the alarms on the monitor at a position close to the patient.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2


Developmental phase

Not applicable


Assessment

Primary outcomes

Gaze ratio (%) defined as a percentage of time spent looking at mannequin and ventilation devices during a given period of time (resuscitation time)

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Cross-over

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

No treatment

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

YES

Concealment

No need to know


Intervention

No. of arms

3

Purpose of intervention

Diagnosis

Type of intervention

Device,equipment

Interventions/Control_1

Positive pressure ventilation simulation is performed according to the resuscitation scenario, using a mannequin for neonatal resuscitation practice.
The neonatal respiratory function monitor (NRM-1300) and flow adapter that can measure and display tidal volume and pressure are attached to a ventilation device.
The subject wears an eye tracker, and the viewpoint will be tracked and recorded.
The standard methods for evaluating the effectiveness of positive pressure ventilation in neonatal resuscitation are (1) physical findings such as thoracic elevation, and (2) vital signs detected by pulse oximeter or heart rate monitoring. The subjects will have simulation training in each of the following three evaluation methods: 1) the standard methods described above, 2) 1) with the addition of the respiratory function monitor (NRM-1300), 3) 2) with the addition of the visual feedback device (PPV assist) in three different orders.

Control: The standard methods only

Interventions/Control_2

Interventions(1): The standard methods with the addition of the respiratory function monitor (NRM-1300)

Interventions/Control_3

Interventions(2): The standard methods with the addition of the respiratory function monitor (NRM-1300) and the visual feedback device (PPV assist)

Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Doctor at National Center for Child Health and Development (Tokyo, Japan)

Key exclusion criteria

-Have not finished neonatal resuscitation training.
-Need visual correction (glasses or contact lenses) for daily life but do not wear contrast lenses, or cannot see within 2 feet (24 cm) with the naked eye (no glasses)

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Tetuya
Middle name
Last name Isayama

Organization

National Center for Child Health and Development

Division name

Division of Neonatology Center for Maternal-Fetal, Neonatal and Reproductive Medicine

Zip code

157-8535

Address

2-10-1, Okura, Setagaya-ku, Tokyo, Japan

TEL

03-3416-0181

Email

isayama-t@ncchd.go.jp


Public contact

Name of contact person

1st name Yasuhisa
Middle name
Last name Ikuta

Organization

National Center for Child Health and Development

Division name

Division of Neonatology Center for Maternal-Fetal, Neonatal and Reproductive Medicine

Zip code

157-8535

Address

2-10-1, Okura, Setagaya-ku, Tokyo, Japan

TEL

03-3416-0181

Homepage URL


Email

ikuta-y@ncchd.go.jp


Sponsor or person

Institute

National Center for Child Health and Development

Institute

Department

Personal name



Funding Source

Organization

Self funding

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

National Center for Child Health and Development

Address

2-10-1, Okura, Setagaya-ku, Tokyo, Japan

Tel

03-3416-0181

Email

rinri@ncchd.go.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 02 Month 08 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2021 Year 12 Month 16 Day

Date of IRB

2022 Year 12 Month 28 Day

Anticipated trial start date

2022 Year 02 Month 08 Day

Last follow-up date

2022 Year 03 Month 31 Day

Date of closure to data entry

2022 Year 08 Month 31 Day

Date trial data considered complete

2022 Year 08 Month 31 Day

Date analysis concluded

2022 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2022 Year 02 Month 08 Day

Last modified on

2023 Year 03 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000053390